Li Hui Chang
Director of Finance/CFO bij FORMOSA OPTICAL TECHNOLOGY CO.,LTD.
Profiel
Li Hui Chang is currently working as a Director at Polylite Taiwan Co. Ltd., a Director at Essilor Amera Pte Ltd., and as the Vice President-Finance & Accounting Office at Formosa Optical Technology Co., Ltd.
Mr. Chang completed their undergraduate degree at Fu Jen Catholic University.
Actieve functies van Li Hui Chang
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Director of Finance/CFO | 06-11-1995 |
| POLYLITE TAIWAN CO., LTD. | Director/Board Member | 01-06-2006 |
Essilor Amera Pte Ltd.
 Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Director/Board Member | - |
Opleiding van Li Hui Chang
| Fu Jen Catholic University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FORMOSA OPTICAL TECHNOLOGY CO.,LTD. | Health Technology |
| POLYLITE TAIWAN CO., LTD. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Essilor Amera Pte Ltd.
Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses. | Health Technology |
